Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r11data as of 9 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

Rivia AG

History from 13 Jan 2022

UID
CHE-420.092.496
Legal form
AG
Canton
ZH
Founded
13 Jan 2022
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 282k
70k141k211k282k18 Mar 2024 · CHF 150k15 May 2024 · CHF 217k25 Feb 2026 · CHF 282kRound announced 18 Mar 2026202420252026
  • shares
  • Vorzugsaktien
  • Vorzugsaktien Pre-Seed
  • Vorzugsaktien Seed 1
  • Vorzugsaktien Seed 2
  • Vorzugsaktien Series A
  • round announced

Record

  1. Company formed

    Founded 13 Jan 2022

    SHAB HR01-1005383897 ↗
  2. Name changed

    Rivia SA → Rivia AG

    SHAB HR02-1005926967 ↗
  3. Capital increase

    Not assessed

    Issued from conditional capital

    Nominal capital
    100’000 → 150’000
    Shares
    1’000’000 → 1’500’000
    New shares, % of post-step shares
    33.3% (500’000 new)

    Aktienkapital neu: CHF 150'000.00 [bisher: CHF 100'000.00]. Liberierung Aktienkapital neu: CHF 150'000.00 [bisher: CHF 100'000.00]. Aktien neu: 1'500'000 Namenaktien zu CHF 0.10 [bisher: 1'000'000 Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005987504 ↗
  4. Capital increase

    Not assessed

    Paid in cash and by other means

    Nominal capital
    150’000 → 216’793.43
    Shares
    1’500’000 → 21’679’343
    New shares, % of post-step shares
    — (nominal value per share changed)
    Share classes
    15’000’000 × CHF 0.01 · 6’679’343 × CHF 0.01 Vorzugsaktien

    Aktienkapital neu: CHF 216'793.43 [bisher: CHF 150'000.00]. Liberierung Aktienkapital neu: CHF 216'793.43 [bisher: CHF 150'000.00]. Aktien neu: 15'000'000 Namenaktien zu CHF 0.01 und 6'679'343 Namenaktien zu CHF 0.01 (Vorzugsaktien) [bisher: 1'500'000 Namenaktien zu CHF 0.10].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1006032214 ↗
  5. Capital increase

    Confirmed round

    Paid in cash

    Nominal capital
    216’793.43 → 281’609.25
    Shares
    21’679’343 → 28’160’925
    New shares, % of post-step shares
    23.0% (6’481’582 new)
    Share classes
    12’056’881 × CHF 0.01 · 1’327’590 × CHF 0.01 Vorzugsaktien Pre-Seed · 798’376 × CHF 0.01 Vorzugsaktien Seed 1 · 6’498’967 × CHF 0.01 Vorzugsaktien Seed 2 · 7’479’111 × CHF 0.01 Vorzugsaktien Series A

    Aktienkapital neu: CHF 281'609.25 [bisher: CHF 216'793.43]. Liberierung Aktienkapital neu: CHF 281'609.25 [bisher: CHF 216'793.43]. Aktien neu: 12'056'881 Namenaktien zu CHF 0.01, 1'327'590 Namenaktien zu CHF 0.01 (Vorzugsaktien Pre-Seed), 798'376 Namenaktien zu CHF 0.01 (Vorzugsaktien Seed 1), 6'498'967 Namenaktien zu CHF 0.01 (Vorzugsaktien Seed 2) und 7'479'111 Namenaktien zu CHF 0.01 (Vorzugsaktien Series A) [bisher: 15'000'000 Namenaktien zu CHF 0.01 und 6'679'343 Namenaktien zu CHF 0.01 (Vorzugsaktien)].

    From the SHAB entry · German original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5
    • A new class of preferred shares was created.+1.5

    Classifier score 0.96 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006579027 ↗
  6. Round announced

    matched to a capital increase · high match confidence

    Announcement ↗

Published by 9 Oct 2026